Mohamed F Doheim/X
Sep 20, 2025, 14:55
Stroke Outcomes: NIHSS-24h as a Key Predictor Following Thrombectomy
Mohamed F Doheim, Faculty Instructor (Research) at NIH StrokeNet, shared a post on X:
”Our recent article shows that binary NIHSS-24h (cutoff = 10; AUC 0.86) is a strong predictor of outcomes after EVT in VBAO patients.”
Title: National Institutes of Health Stroke Scale at 24 Hours is a Strong Predictor of Outcomes After Thrombectomy in Vertebrobasilar Occlusion
Authors: Takehiro Katano, Mohamed F. Doheim, Abdullah M. Al-Qudah, Lucas Rios Rocha, Nirav Bhatt, Marcelo Rocha, Mathew Stary, Jussie C. Lima, Michael Lang, Bradley A. Gross, Alhamza R. Al-Bayati, Raul G. Nogueira
Read the full article here.
Stay updated with Hemostasis Today.
Abdullah M. Al-Qudah
Alhamza R. Al-Bayati
Bradley A. Gross
Health
Hematology
Hemostasis Center
Jussie C. Lima
Lucas Rios Rocha
Marcelo Rocha
Mathew Stary
Medicine
Michael Lang
Mohamed F. Doheim
NIHSS-24h
Nirav Bhatt
Raul G. Nogueira
stroke
Stroke Outcome
Takehiro Katano
Thrombectomy
thrombosis
Vertebrobasilar Occlusion
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals
Sep 29, 2025, 12:54
Sep 29, 2025, 12:33
Sep 29, 2025, 06:23
Sep 29, 2025, 05:06
Sep 29, 2025, 04:28